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Abstract
Background: Early response to treatment has been shown to be a predictor of later clinical outcomes in eating
disorders (EDs). Specifically, early weight gain trajectories in anorexia nervosa (AN) have been shown to predict
higher rates of later remission in inpatient treatment. However, no study has, as of yet, examined this phenomenon
within outpatient treatment of first episode cases of AN or in emerging adults.
Methods: One hundred seven patients with AN, all between the ages of 16 and 25 and with an illness duration of
< 3 years, received treatment via the first episode rapid early intervention in eating disorders (FREED) service
pathway. Weight was recorded routinely across early treatment sessions and recovery outcomes (BMI > 18.5 kg/m2
and eating psychopathology) were assessed up to 1 year later. Early weight gain across the first 12 treatment
sessions was investigated using latent growth mixture modelling to determine distinct classes of change. Follow-up
clinical outcomes and remission rates were compared between classes, and individual and clinical characteristics at
baseline (treatment start) were tested as potential predictors.
Results: Four classes of early treatment trajectory were identified. Three of these classes (n = 95), though differing
in their early change trajectories, showed substantial improvement in clinical outcomes at final follow-up. One
smaller class (n = 12), characterised by a ‘higher’ start BMI (> 17) and no early weight gain, showed negligible
improvement 1 year later. Of the three treatment responding groups, levels of purging, depression, and patient
reported carer expressed emotion (in the form of high expectations and low tolerance of the patient) determined
class membership, although these findings were not significant after correcting for multiple testing. A higher BMI at
treatment start was not sufficient to predict optimal clinical outcomes.
Conclusion: First episode cases of AN treated via FREED fit into four distinct early response trajectory classes. These
may represent subtypes of first episode AN patients. Three of these four trajectories included patients with
substantial improvements 1 year later. For those in the non-response trajectory class, treatment adjustments or
augmentations could be considered earlier, i.e., at treatment session 12.
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Plain English summary
A key feature of anorexia nervosa (AN) is an unhealthily low body weight. Previous studies show that more weight
gained early in inpatient treatment leads to better outcomes. This study tried to see if this was also true for
outpatients receiving treatment for the first time. All participants were emerging adults between the ages of 16 and
25 who had been ill for less than 3 years. Weight was recorded across the first 12 weekly treatment sessions.
Statistics showed that the patients fit roughly into four different groups in early treatment, each with different
starting weights and rates of weight gain in the first 12 treatment sessions. The group a patient belonged to could
sometimes be predicted by vomiting behaviours, level of depression, and patients’ perception of parental tolerance
and expectations at the start of treatment. Out of the four groups, three did relatively well 1 year later, but one
small group of patients did not. This small group had a higher starting weight than many of the other groups but
did not gain any weight across the first 12 sessions. These patients could benefit from a change or increase in the
amount or intensity of treatment after the first 12 treatment sessions
Keywords: Anorexia nervosa, Eating disorder, Early intervention, Outpatient, Treatment, Growth mixture modelling
Introduction
Outpatient psychological therapies for adults with an-
orexia nervosa (AN) are associated with modest im-
provement in body mass index (BMI) and other
outcomes, and there is no evidence for superiority of
any specific approach. Such findings highlight the need
to further develop and improve treatments [1]. A better
understanding of individual characteristics, moderators,
and trajectories in treatment is crucial in order to tease
apart what works best for whom (i.e., to develop a preci-
sion medicine approach), and also to reduce unsuccess-
ful treatment attempts [2].
Early response to treatment has been identified as a
possible predictor of later clinical outcomes in eating
disorders (EDs) [3, 4], i.e., those who have early symp-
tom reduction after starting treatment are likely to have
better outcomes at end of treatment and at later follow-
ups. Recent studies evaluating early treatment response
in EDs have adopted a latent growth modelling approach
[5–7]. The purpose of this approach is to identify mean-
ingful subgroups of patients with distinct growth (recov-
ery) trajectories within a larger heterogeneous patient
group [8]. Specific to AN, weight gain during early treat-
ment has been shown to predict later rates of remission
[9]. Application of a latent growth modelling approach
to the treatment of AN, with the identification of these
early weight gain subgroups, and individual and clinical
characteristics that predict membership to these groups,
may allow clinicians to determine the prognosis of pa-
tients and consequently tailor treatment to their needs.
Previous studies looking at treatment response in AN
using a latent growth modelling approach have largely fo-
cused on full and partial hospitalisation settings. In a study
of 102 adolescents and young adults with AN who were
partially hospitalised, Berona, Richmond, and Rienecke
found three distinct early weight gain trajectories: a slow,
a moderate, and a rapid class. The rapid weight gain class
membership was predicted by three characteristics at
baseline (i.e., treatment start): the presence of compensa-
tory behaviours, lower parental expressed emotion, and
the absence of a comorbid mood disorder [10]. Similarly,
in an inpatient sample, Makhzoumi et al. found that a
rapid weight gain trajectory was associated with regular
restriction, bingeing, and purging, and further determined
that a faster weight gain trajectory was associated with
greater weight restoration at follow-up [11].
Most recently, Wade et al. investigated the trajectories
of early weight gain in AN during outpatient treatment
[12]. Four distinct trajectories were found, and the class
with the highest weight gain over the early treatment
period had the greatest rates of later remission. Results
also showed that a class with higher BMI at treatment
start did not automatically have better clinical outcomes
than a class with a low BMI at treatment start [12]. This
supports the need for the consideration of growth pat-
terns rather than only severity of BMI at baseline for ap-
propriate treatment selection.
To date, no studies have specifically assessed early
weight gain trajectories for outpatients experiencing
their first episode of AN, i.e., in a treatment naïve state.
This is important to assess as first episode AN patients
tend to have a more favourable treatment response com-
pared to those with a more established illness [13, 14].
Thus, previous trajectory analyses in outpatient AN may
not generalise to a first episode population.
In the current study we attempt to address this gap,
with the aim to:
1. Investigate typical weight gain trajectory classes in
outpatient treatment for first episode AN.
2. Evaluate baseline variables to determine if any
predict membership of trajectory classes.
3. Evaluate outcome (remission) variables of each
class.
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Methods
Design
This study involves an analysis of weekly BMI and ED
behavioural symptom data, logged weekly by clinicians
during the multi-centre FREED-Up study. This study
had a quasi-experimental pre-post design comparing 278
First Episode Rapid Early Intervention for Eating Disor-
ders (FREED) patients to 224 treatment-as-usual con-
trols, who were similar patients seen in the 2 years
before FREED was introduced. The study and its find-
ings are described in detail elsewhere [15, 16].
Participants
Participants were consecutive referrals from four special-
ist ED centres in England. All were emerging adults who
entered treatment for a first episode ED (illness duration
< 3 years) between 2016 and 2018 and were between 16
and 25 years old at study enrolment. Patients were ex-
cluded if they needed an immediate inpatient admission,
were pregnant, had a severe learning disability, or had a
comorbid physical or mental disorder needing primary
treatment (e.g., psychosis). One hundred and twenty-one
met diagnostic criteria for DSM-5 AN or other specified
feeding and eating disorder [17] at assessment and had a
BMI < 18.5 at the start of treatment. Of these, 107 pa-
tients (88.4%) had symptom log data available, which
constituted our final sample.
Procedure
Details of the FREED service model and care pathway
has been previously described [18–21]. In brief, FREED
patients were given a phone call within 48 h of referral
to screen for eligibility for the service, and to increase
engagement. Patients potentially suitable for FREED
were offered a clinical assessment adapted for FREED,
taking a biopsychosocial, person-centred approach, with
family involvement encouraged. The adapted assessment
emphasised the importance of early intervention on ED-
related changes to the brain and body. Patients were
then allocated to treatment, with the aim of starting this
within 2 weeks of assessment. Treatment was NICE-
concordant [22], evidence based (e.g., ED focused cogni-
tive behavioural [CBT-ED] or Maudsley Anorexia Ner-
vosa Treatment for Adults [MANTRA]), tailored to the
needs of emerging adults in early-stage illness, and typic-
ally lasting between 20 and 30 individual sessions. Devel-
opmentally informed adaptations included a focus on
early dietetic involvement and nutritional change, reduc-
tion of any unhelpful/excessive social media and health-
related app use, effective management of transitions
(e.g., to university, in treatment), the developmental




Therapist-recorded BMI and ED behaviour frequency at
weekly therapy sessions.
Eating disorder examination questionnaire (EDE-Q)
The EDE-Q [23] is a 28-item measure which captures
the frequency and severity of ED behaviours over the
past 28 days. It provides a score on four subscales (diet-
ary restraint, eating concerns, shape concerns, and
weight concerns) as well as a global score. A total global
score > 2.8 suggests a clinical ED. [24] The EDE-Q also
measures the frequency of binge and compensatory be-
haviours over the last 28 days [23].
Depression anxiety stress scale-21 (DASS-21)
The DASS-21 [25] is a 21-item screener which captures
mood over the past week. It contains subscales for de-
pression, anxiety, and distress, as well as a global score.
Clinical impairment assessment (CIA)
The CIA [26] is a 16-item measure used to evaluate psy-
chosocial impairment from an ED. It covers four do-
mains: mood and self-perception, cognitive function,
work performance, and interpersonal function.
Level of expressed emotion (LEE)
The LEE [27] is a 60-item true or false questionnaire
used to evaluate the perception of expressed emotion of
one’s most influential relationship. It includes subscales
for attitude toward illness, emotional response, intrusive-
ness, and low tolerance/high expectations.
Analysis
Derivation of latent classes
The rate of change in weekly BMI over the first 12 ther-
apy sessions (the approximate halfway point) was used
to determine latent class membership in the current
study. Patients who took a break for more than 30 days
between treatment sessions (e.g., for exams, holidays)
during the first 12 weeks only had data included up to
the point of absence. Latent growth mixture modelling
(LGMM) was used, which categorises individuals with
similar patterns of longitudinal change into subgroups
while also allowing for individual variation [28]. The op-
timal number of subgroups was informed by fit statistics
including the Akaike Information Criteria (AIC), the
Bayesian Information Criteria (BIC), and the sample-size
adjusted Bayesian Information Criteria (aBIC), with
lower absolute values indicating a better model fit. En-
tropy, or the separateness of the classes, was also evalu-
ated in each model, with a value above 0.8 suggesting
good separation [29]. Finally, the Vuong-Lo-Mendell-
Rubin likelihood ratio test (VLMR-LRT) and the
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adjusted Lo-Mendell-Rubin likelihood ratio test (ad-
justed LRT) were used to compare a model with X clas-
ses to a model with X-1 classes, with a p value < 0.05
indicating that a model with X classes fits better the
model with X-1 classes. LGMM was first conducted with
a one class model, increasing up to a five-class model.
Analysis was performed in Mplus version 8.4 (Muthén &
Muthén, 2019).
Latent classes and clinical characteristics
Latent classes were compared on baseline variables (pre-
dictors) and 12-month follow-up variables (outcomes)
using a 3-step approach as recommended by Herle et al.
[30]. One way analysis of variance (ANOVA) was used
to compare trajectory classes on continuous variables
(e.g., EDE-Q score) while chi-squared and Fisher’s exact
tests were used for categorical variables (e.g., ethnicity).
Significant findings were then subject to post-hoc testing
to determine which classes differed. Binge, purge, and
laxative use frequencies were zero-inflated and so groups
were compared on the presence or absence of these be-
haviours. Remission was defined as BMI > 18.5 kg/m2
and an EDE-Q global score < 2.8 as suggested by Mond
et al. [24]. For participants with missing data at the 12-
month follow-up, data from the 6-month timepoint were
used. Analysis was done in SPSS version 26.
Results
Latent classes
Fit statistics from the latent class analyses are presented
in Table 1. One to five class solutions were tested, with
entropy (i.e., separateness of the classes) increasing with
each subsequent analysis. As recommended, the best fit-
ting solution was determined by both fit statistics and
existing findings/previous theory. Following previous
evidence, we anticipated a three to four class solution
[10–12, 31]. Two of the three fit statistics (AIC and
aBIC) were lowest for the four-class solution. Thus, a
four-class solution best fit the data, as is presented in
Fig. 1. This includes one class starting with a higher
BMI, making little change across the first 12 therapy ses-
sions (higher, stable). A second class also starts at a
higher BMI but makes steady, moderate gains across this
same time period (higher, moderate). A third class starts
treatment with a very low BMI but makes large gains in
early treatment (low, rapid). Finally, a fourth class begins
at a moderate BMI and makes little early change
(medium, stable).
Baseline predictors
Baseline characteristics of each latent class can be seen
in Table 2. Participants in Class 2 (high, moderate) were
significantly more likely to report higher scores on de-
pression than Class 3 (low, rapid) and higher patient re-
ported carer expressed emotion (low tolerance/greater
expectations) compared to participants in Class 4
(medium, stable). Class 2 also had the highest rates of
binge, purge, and laxative use behaviours at baseline, al-
though only the presence of purging significantly pre-
dicted membership into Class 2 compared to Class 3
(low, rapid). These baseline findings are non-significant
after a Bonferroni correction.
Recovery outcomes
Outcome characteristics of each latent class are pre-
sented in Table 3.
Follow-up BMI at 12 months was higher for Class 2
(high, moderate) compared to Class 1 (high, stable), al-
though this was no longer significant after a Bonferroni
correction to account for multiple testing.
The trajectory with the lowest starting BMI (Class 3:
low, rapid) had significantly greater BMI change be-
tween treatment start and 12-month follow-up than
Class 1 (high, stable) and Class 2 (high, moderate).
No other significant differences between classes were
found. Class 1 (high, stable) had the lowest proportion
of weight restored participants (BMI > 18.5 kg/m2) and
the lowest rates of full remission (10%), although these
finding were not statistically significant.
Discussion
Our first aim was to investigate the typical trajectory
classes of early weight gain across outpatients with first
episode AN. Fit statistics suggested that a four-class so-
lution best fit the data. This consisted of 1) a class of pa-
tients with relatively high BMI (> 17 kg/m2) at treatment
Table 1 Fit statistics for latent growth mixture modelling
Classes # free parameters AIC BIC aBIC Entropy aLRT P
1 19 1602.64 1653.60 1593.56 – –
2 23 1593.16 1654.85 1582.17 0.76 0.32/0.34
3 27 1589.36 1661.78 1576.47 0.87 0.34/0.36
4 31 1584.38 1667.53 1569.58 0.88 0.48/0.49
5 35 1588.67 1682.55 1571.96 0.90 0.24/0.24
aBIC sample-size adjusted Bayesian information criteria, AIC Akaike information criteria, BIC Bayesian information criteria
aLRT likelihood ratio tests (Vuong-Lo-Mendell-Rubin likelihood ratio test; adjusted Lo-Mendell-Rubin adjusted LRT test) quantify specific comparisons between the
model of interest and a model with one fewer class, C-1
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start and stable weight (i.e., no improvement) across
early treatment (high, stable), 2) a class with relatively
high BMI at treatment start but with moderate weight
gains (about half a BMI point) across early treatment
(high, moderate), 3) a class with a medium starting BMI
relative to other classes but with little improvement over
early treatment (medium, stable), and 4) a class with ex-
tremely low BMI (< 15 kg/m2) and fast improvement
across early treatment (low, rapid). This is similar to
Wade et al., who found four classes with similar start
BMIs (two with higher values, one medium, and one
low) [12].
The second aim was to determine whether any charac-
teristics may predict class membership. Those in Class 2
(high, moderate) were more likely to report higher levels
of depression than Class 3 (low, rapid) and higher re-
ported parental expressed emotion (greater expecta-
tions/lower levels of tolerance) compared to those in
Class 4 (medium, stable). A previous study by Berona
et al. found that the presence of a comorbid mood dis-
order and higher levels of parental expressed emotion
were predictive of slower early weight gain [10]. How-
ever, it is still unclear exactly how depression/mood and
parental expressed emotion contribute to trajectory
change classes in first episode AN. For example, depres-
sion scores were more severe in a group (Class 2) with
higher starting BMI and moderate trajectory improve-
ments and lower in a group (Class 3) with poorer
starting BMI and rapid trajectory improvements. Future
research will need to tease apart the relationship be-
tween these predictive variables and their relationship to
intercept (start BMI) and slope (trajectory change).
Class 2 (high, moderate) also had the highest rates of
binge, purge, and laxative use behaviours at baseline, al-
though only the presence of purging predicted member-
ship into Class 2 compared to Class 3 (low, rapid).
Previous work has found compensatory behaviours to be
predictors of more rapid weight gain trajectories in early
inpatient treatment [10, 11]. However, it is difficult to
directly compare our results to this previous work as
these studies focused on the rate of weight gain irre-
spective of a patient’s starting weight (i.e., all patients
started at ‘zero’). A transdiagnostic study by Espel-
Huynh et al. found that the presence of vomiting at
baseline was more common in patients with a rapid re-
sponse trajectory in early treatment as measured by ED
symptoms and emotional functioning [5]. As such, com-
pensatory behaviour should be considered a specific
variable of interest in any future treatment response tra-
jectory studies. Overall, after correcting for multiple test-
ing, there were no robust baseline predictors of later
clinical outcomes.
Our third aim was to compare classes by later clinical
outcomes. Three of the four classes achieve substantial
improvements at 12-months. For the classes with a
lower starting BMI, these improvements were ‘propped
Fig. 1 The selected four class model as best fits the data, here showing weight gain across early treatment sessions
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up’ by higher use of additional intensive treatments, al-
though the difference in use of intensive treatments was
not significantly different between classes. While these
three classes had differing early treatment trajectories,
i.e., some classes responding rapidly and others taking
longer, all three achieved substantial and similar clinical
outcomes. Conversely, those in Class 1 (high, stable) had
the lowest rate of remission (10%) compared to the
other classes (31–43%). This demonstrates that, similar
to Wade et al.’s findings [12], a higher BMI at treatment
start is not sufficient to predict later remission or even
weight restoration in AN, and this seems to be even
more pronounced in first episode cases.
One clinical implication of these results is the consid-
eration of adjunct or alternative treatments for those
with first episode AN. In our study, a small group (n =
12) of patients with a ‘relatively’ higher BMI (i.e., > 17)
who do not gain weight over the first 12 sessions (Class
1: high, stable) had the poorest recovery rates at 12
months, at only 10%. It may be that a change or aug-
mentation to therapy for a first episode patient is more
suitable at the mid-point of treatment rather than simply
carrying on ‘as is.’ This could include intensifying ses-
sion frequency, increasing family involvement, or
changing treatment setting (e.g., day treatment). Al-
ternatively, adjunctive medications (e.g., antidepres-
sants or olanzapine) focused on the ED or a
comorbidity might be considered [32], or emerging
treatments such as cognitive remediation therapy [33],
or neuromodulation approaches [34].
Table 2 Baseline characteristics (predictors) of each latent class, with mean and standard deviation
Variable Class1, n = 12
(high, stable)
Class2, n = 41
(high, moderate)
Class3, n = 20
(low, rapid)
Class4, n = 34
(medium, stable)
Group comparison
Age (years) 19.50 (1.45) 19.22 (2.15) 20.10 (2.08) 20.15 (2.32) F(3,103) = 1.46, p = 0.23
DUED (months) 14.73 (9.19) 16.98 (12.17) 16.05 (9.01) 16.88 (10.83) F(3,101) = 0.15, p = 0.93
Baseline BMI 17.91 (0.66) 1 17.66 (0.97) 1 14.74 (0.65) 2 16.23 (0.72) 3 F(3,87) = 3.44, p = 0.02 a
Ethnicity, n (%) X2 (3) = 4.57, p = 0.21
White 9/11 (81.8%) 28/36 (77.8%) 17/19 (89.5%) 22/32 (68.8%)
BAME 2/11 (18.2%) 8/36 (22.2%) 2/19 (10.5%) 10/32 (31.3%)
Occupation, n (%) X2 (6) = 3.64, p = 0.74
Student 10/12 (83.3%) 28/41 (68.3%) 12/20 (60.0%) 21/34 (61.8%)
Employed 1/12 (8.3%) 7/41 (17.1%) 6/20 (30.0%) 7/34 (20.6%)
Unemployed 1/12 (8.3%) 6/41 (14.6%) 2/20 (10.0%) 6/34 (17.6%)
Home, n (%) X2 (3) = 6.84, p = 0.08
With family 3/10 (30.0%) 29/40 (72.5%) 10/19 (52.6%) 21/34 (61.8%)
Other 7/10 (70.0%) 11/40 (27.5%) 9/19 (47.4%) 13/34 (38.2%)
EDE-Q 4.42 (1.21) 3.95 (1.25) 3.62 (1.28) 3.33 (1.57) F(3,103) = 2.39, p = 0.07
Binge 6/12 (50.0%) 21/41 (51.2%) 9/20 (45.0%) 9/34 (26.5%) X2 (3) = 5.18, p = 0.16
Purge 3/12 (25.0%) 15/41 (36.6%) 1 1/20 (5.0%) 2 5/34 (14.7%) Fisher’s exact = 9.23, p = 0.02 a
Laxative 2/12 (16.7%) 9/41 (22.0%) 3/20 (15.0%) 1/34 (2.9%) Fisher’s exact = 6.26, p = 0.08
DASS - 21 32.83 (14.06) 35.17 (14.04) 27.45 (9.90) 33.50 (14.62) F(3, 103) = 1.48, p = 0.23
Depression 11.92 (4.98) 13.02 (5.61) 1 8.80 (4.51) 2 11.24 (5.56) F(3, 103) = 2.86, p = 0.04 a
Anxiety 8.42 (4.70) 9.49 (5.71) 5.90 (4.04) 9.24 (5.38) F(3,103) = 2.35, p = 0.08
Stress 12.50 (5.90) 12.66 (4.54) 12.75 (4.46) 13.03 (5.18) F(3,103) = 0.05, p = 0.99
CIA 34.83 (8.6) 32.20 (10.86) 32.20 (9.68) 29.76 (11.03) F(3,103) = 0.79, p = 0.50
LEE 13.58 (13.91) 18.26 (11.99) 15.1 (11.52) 11.97 (8.45) F(3, 103) = 2.08, p = 0.53
Intrusiveness 4.92 (3.73) 5.80 (3.88) 4.95 (3.62) 4.64 (2.74) F(3, 102) = 0.74, p = 0.53
Emotional response 2.58 (4.14) 4.50 (3.60) 3.95 (3.89) 2.74 (3.51) F(3, 102) = 1.77, p = 0.16
Attitude toward illness 2.58 (2.61) 3.50 (2.72) 2.60 (2.52) 2.09 (1.48) F(3, 102) = 2.32, p = 0.08
Tolerance/expectations 3.50 (4.08) 4.93 (3.77) 1 3.60 (3.56) 2.50 (2.54) 2 F(3, 102) = 3.12, p = 0.03 a
BAME Black, Asian, and minority ethnic, CIA Clinical Impairment Assessment, DASS-21 Depression, Anxiety, and Stress Scale, 21-item version, DUED duration of
untreated eating disorder, EDE-Q Eating Disorder Examination Questionnaire, LEE Level of Expressed Emotion Scale
1,2,3 Different superscripts indicate significant differences between the classes. For example, Class 2 and Class 3 have significantly different rates of depression. a
Non-significant after Bonferroni correction
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A key limitation of this work is the relatively small
sample size. This may impact the reliability of results,
and as such, these findings should be considered ex-
ploratory. However, the sample size was above the mini-
mum of 100 as recommend for LGMM [5, 35].
Additionally, while patients’ weight for BMI calculations
was measured at each weekly treatment session by a
clinician, all other variables were assessed by self-report.
Data gathered by self-report rely on patient memory and
insight, which may reduce validity. Finally, clinical out-
come data were analysed using complete case analysis
with 6-month outcomes substituted when 12-month
outcomes were unavailable, which poses a risk for bias.
Future research would ideally have longer and more
complete follow-up data.
In conclusions, patients with first episode AN fit into
four distinct trajectory classes, three of which had sub-
stantial weight gain at 12-months. Depression scores,
the presence of purging, and perceived levels of paren-
tal/carer expressed emotion in the form of high expecta-
tions/low levels of tolerance were predictive of class
membership. A higher BMI at treatment start was not
sufficient to produce better weight restoration at 12-
month follow-up. These results are exploratory in nature
and should be interpreted with caution until larger stud-
ies can clarify findings.
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